MedPath
HSA Approval

Estacoxib Capsule 200mg

SIN15792P

Estacoxib Capsule 200mg

Estacoxib Capsule 200mg

August 28, 2019

WELLESTA HEALTHCARE (SINGAPORE) PTE LTD

WELLESTA HEALTHCARE (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantWELLESTA HEALTHCARE (SINGAPORE) PTE LTD
Licence HolderWELLESTA HEALTHCARE (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

M01AH01

celecoxib

Manufacturer Information

WELLESTA HEALTHCARE (SINGAPORE) PTE. LTD.

Adcock Ingram Limited

Active Ingredients

Celecoxib

200.000mg

Celecoxib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Estacoxib Capsule 200mg - HSA Approval | MedPath